Jakob M. Goldmann

NGS analysis for oncology

Jakob is analyzing next-generation sequencing data for pharmaceutical drug development, currently at Byondis. He has been analyzing DNA sequencing data since 2012 and obtained a PhD in computational human genomics. He did research on de novo mutations and wrote scientific publications about germline biology. He coordinates projects in international, multi-disciplinary teams.